Stay updated on MEK162 vs Dacarbazine in NRAS+ Melanoma Clinical Trial
Sign up to get notified when there's something new on the MEK162 vs Dacarbazine in NRAS+ Melanoma Clinical Trial page.

Latest updates to the MEK162 vs Dacarbazine in NRAS+ Melanoma Clinical Trial page
- Check3 days agoChange DetectedThe history now includes a new revision entry labeled v3.6.6 as the latest update. This replaces the previous revision v3.6.5 and reflects an update to the page's version in the history.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedNew revision entry 'Revision: v3.6.5' is added to the study history, and the previous 'Revision: v3.6.4' entry is removed. This updates the history to reflect the latest version of the record in the log.SummaryDifference0.1%

- Check38 days agoChange DetectedA new revision entry v3.6.4 was added to the study record history, replacing the previous v3.6.3. This update reflects a change to the revision history itself rather than to study data.SummaryDifference0.1%

- Check67 days agoChange DetectedRevision label updated from v3.6.0 to v3.6.3 in the page footer. This reflects a newer UI/system update to the record history page.SummaryDifference0.1%

- Check81 days agoChange DetectedRecruitment is now closed (no longer looking for participants) and the record has been updated to revision v3.6.0, replacing the previous revision v3.5.5.SummaryDifference0.3%

- Check88 days agoChange DetectedA new revision label 'Revision: v3.5.5' was added to the page history. The previous label 'Revision: v3.5.4' was removed.SummaryDifference0.1%

Stay in the know with updates to MEK162 vs Dacarbazine in NRAS+ Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the MEK162 vs Dacarbazine in NRAS+ Melanoma Clinical Trial page.